Mitani S, Muro K. No benefit from ramucirumab in first-line chemotherapy?
Transl Gastroenterol Hepatol 2017;
2:30. [PMID:
28529984 PMCID:
PMC5420525 DOI:
10.21037/tgh.2017.03.18]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/18/2017] [Accepted: 03/26/2017] [Indexed: 12/17/2022] Open